MAMohamad-Reza Aghanoori

Mohamad-Reza Aghanoori

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohamad-Reza Aghanoori has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • A. Micheil Innes

    Departments of Medical Genetics and Pediatrics and Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada

    1 shared publication
  • Alexia Bourgois

    Service de Génétique, Centre Hospitalier Universitaire de Caen

    1 shared publication
  • Angie Lichty

    Greenwood Genetic Center

    1 shared publication
  • Antonio Vitobello

    INSERM, CTM UMR1231, équipe GAD, FHU TRANSLAD, Laboratoire de Génomique Médicale Université Bourgogne Europe, CHU Dijon Bourgogne Dijon France

    1 shared publication
  • Boris Keren

    Department of Genetics, La Pitié-Salpêtrière Hospital, Assistance Publique Hospital of Paris

    1 shared publication
  • Brooke Rackel

    Department of Medical Genetics, Cumming School of Medicine, University of Calgary

    1 shared publication

Latest Publications

  • Open Access

    Genetic variants disrupting activity-dependent CELF2 shuttling cause neuronal hyperexcitability, learning deficits, and seizures

    by Michelle Hua, Mohamad-Reza Aghanoori, Melissa MacPherson, Yi Ren, Yifan Yang, Yan Yan Or, Laura Williams, Christopher J. Gafuik, Chloe Quelin, Boris Keren, et al.

    De novo heterozygous variants in the CELF2 gene have recently been associated with a rare neurodevelopmental disorder. However, the mechanisms linking specific variants to distinct clinical phenotypes remain poorly understood. Here, we report a new cohort of 14 individuals with de novo CELF2 variants, providing evidence that variants causing CELF2 cytoplasmic mislocalization, but not its loss-of-function, are associated with seizures. Using proband induced pluripotent stem cell-derived neurons and transgenic mouse models, we show that CELF2 undergoes activity-dependent nucleocytoplasmic shuttling in excitatory neurons, and its cytoplasmic retention causes neuronal hyperexcitability, leading to learning and memory deficits. In the cytoplasm, CELF2 regulates mRNAs critical for synaptic functions and neuronal excitability implicated in epileptic seizures and intellectual disability. Through drug screening, we identify AKT signaling as a key regulator of CELF2 shuttling and a target for treating CELF2-associated hyperexcitability. Our findings expand the clinical and genetic spectrum of CELF2-related neurodevelopmental disorders and reveal variant-specific mechanisms that link CELF2 mislocalization to neuronal hyperexcitability, learning deficits, and epileptic seizures. One Sentence Summary: CELF2 variants link protein mislocalization to neuronal hyperexcitability, learning deficits, and epileptic seizures.


  • AI-assisted multi-OMICS analysis reveals new markers for the prediction of AD

    by Hamid Latifi-Navid, Saeedeh Mokhtari, Sepideh Taghizadeh, Fatemeh Moradi, Dorsa Poostforoush-Fard, Sakineh Alijanpour, Mohamad-Reza Aghanoori